P-121: Real-world glycemic outcomes of advanced hybrid closed-loop system (AHCL) in young children aged 2–6 years with type 1 diabetes across Latin America
The MiniMed™ 780G (MM780G) system is approved for children aged 2–6 years with type 1 diabetes (T1D) in Europe, Middle East and Africa (EMEA) following the LENNY randomized controlled trial, but its use in Latin America (LATAM) is currently off/label. Characterizing real-world outcomes of this practice is necessa...